This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (403) Genomics and Bioinformatics for Clinical Use (47)

Published on in Vol 8, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13848, first published .
Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study

Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study

Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study

Authors of this article:

Beatriz Manzor Mitrzyk1 Author Orcid Image ;   Reema Kadri2 Author Orcid Image ;   Karen B Farris1 Author Orcid Image ;   Vicki L Ellingrod1 Author Orcid Image ;   Michael S Klinkman2 Author Orcid Image ;   Mack T Ruffin IV3 Author Orcid Image ;   Melissa A Plegue2 Author Orcid Image ;   Lorraine R Buis2 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Jukic M, Milosavljević F, Molden E, Ingelman-Sundberg M. Pharmacogenomics in treatment of depression and psychosis: an update. Trends in Pharmacological Sciences 2022;43(12):1055 View
  2. Roberts B, Cooper Z, Miljevic A, Stanley S, Majda B, Collins K, Baltic S, Lindsey-Temple S, Akkari P, Hood S, Rodger J. PharmacoGENEtics in Youth Depression (GENE-YD) Study protocol: a pilot triple-blinded randomised controlled trial using pharmacogenetics to tailor antidepressant treatment in young Australians. BMJ Open 2025;15(11):e103644 View